Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Nikola, Super Micro Computer And Other Big Losers From Monday

Published 20/09/2022, 10:12
Updated 20/09/2022, 11:10
© Reuters.  Nikola, Super Micro Computer And Other Big Losers From Monday

U.S. stocks closed higher with the Dow Jones gaining around 197 points on Monday. Here is the list of some big stocks recording losses in the previous session.

  • Sotera Health Company (NASDAQ: SHC) shares dipped 33.3% to close at $9.83.
  • AMTD Digital Inc. (NYSE: HKD) declined 14.8% to close at $92.00.
  • Pagaya Technologies Ltd. (NASDAQ: PGY) fell 11.2% to close at $6.99.
  • Nikola Corporation (NASDAQ: NKLA) dropped 10.6% to close at $4.58 after CNBC's Jim Cramer recently made bearish comments on the stock.
  • HUTCHMED (China) Limited (NASDAQ: HCM) fell 9.5% to settle at $10.95.
  • ImmunityBio, Inc. (NASDAQ: IBRX) fell 9.1% to close at $5.51.
  • BioNTech SE (NASDAQ: BNTX) dropped 8.6% to settle at $133.22.
  • Moderna , Inc. (NASDAQ: NASDAQ:MRNA) fell 7.1% to close at $127.90. Moderna’s COVID-19 vaccine would be used in a World Health Organization effort to develop mRNA shots to increase production and access for developing countries, Bloomberg reported.
  • Udemy, Inc. (NASDAQ: UDMY) declined 7.1% to settle at $13.20.
  • Super Micro Computer, Inc. (NASDAQ: SMCI) dropped 7% to close at $57.97. Susquehanna downgraded Super Micro Computer from Positive to Neutral.
  • Turkcell Iletisim Hizmetleri A.S. (NYSE: TKC) declined 6.9% to settle at $2.97.
  • bluebird bio, Inc. (NASDAQ: BLUE) fell 6.5% to close at $5.93. bluebird bio disclosed that the Food and Drug Administration approved its gene therapy for a rare neurodegenerative disease.
  • Novavax, Inc. (NASDAQ: NVAX) dropped 6.5% to settle at $28.43. Shares of several vaccine companies at large traded lower after President Biden in a '60 Minutes' interview said the Covid pandemic is over.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.